NMAI Nuveen details multiasset income market positioning and capital allocation plans in its latest quarterly earnings report Is Vera Therapeutics VERA stock slowing down Vera Therapeutics reports wider loss on 63 EPS miss ASML Holding NV ASML Valuation Assessment Following a 117 12Month Share Price Surge